Top Tech Companies (764)
Don't see your company?
Create a company profile
Click here to find out how Mikart Pharmaceuticals can help you - a CDMO leader in contract pharmaceutical development, manufacturing and packaging services.
Fzata, Inc. is a pre-clinical stage biopharmaceutical company based in Halethorpe, MD within the vibrant BioHealth Capital Region. Fzata’s vision is to reduce health inequities by expanding patient access to therapeutic biologics. This is made possible with our proprietary first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. BioPYM enables orally administered yeast micro-factories to make biologic therapeutics “on-site” in the gut for treatment of GI disorders like infectious diseases, inflammation, metabolic diseases, (e.g., diabetes), colon cancer, and more. Our oral biologic drug candidates are intended to help patients that inject biologic medicine by 1) improving patient accessibility to biologics with affordable, non-refrigerated, convenient oral capsules, 2) improving patient compliance with no needles and no need for health-care administration and 3) improving patient outcomes given the expected high safety profile for chronic use.
Otsuka is a healthcare company.
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,200 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, stability storage and testing and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited. The institute works through collaborating partners and organizations, coordinating and driving the full spectrum of biopharmaceutical development activities, including pre-clinical development, full clinical development (from phase 1 through to and including phase 3), and global regulatory interactions. The institute focuses on programs aimed at reducing the burden of TB, malaria, diarrheal diseases, and maternal, newborn, and child illnesses worldwide. As an affiliate of the Bill & Melinda Gates Foundation, the institute’s programs are focused on disease and health areas of primary focus at the foundation. The interventions under study and development are derived from sources both within and external to the foundation.
Discover how Excelra, a leader in biopharma data and analytics, uniquely blends scientific understanding with technological expertise. This dual mastery empowers innovative drug discovery and development, transforming research data into actionable insights for groundbreaking discovery. 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 Excelra’s interdisciplinary approach combines life science expertise with cutting-edge technology. This leads to confident, data-centric decisions, simplifying your data-driven drug discovery journey and accelerating your research. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗖𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 At Excelra, collaboration is key. By co-creating solutions, we amplify your team's capabilities, blending scientific insight and technological acumen for more valuable discoveries and greater project control. 𝗙𝗿𝗼𝗺 𝗖𝗵𝗮𝗼𝘀 𝘁𝗼 𝗖𝗹𝗮𝗿𝗶𝘁𝘆: 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗗𝗮𝘁𝗮 We navigate the complexities of drug discovery, enhancing your success by structuring chaotic data into actionable insights, leveraging our scientific and technological prowess. 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗬𝗼𝘂𝗿 𝗚𝗼𝗮𝗹𝘀 Your goals of faster drug development and better patient outcomes are central to our mission. Committed to delivering insights and tangible progress, we ensure each data point contributes to your innovation journey, helping you 'Excelrate' towards success. 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 Join us in redefining drug development. Our services span across the life science value chain, from molecule to market. At Excelra, each data point is a step towards a healthier future. Discover how partnering with us can 'Excelrate' your healthcare innovations.
Reliable Biopharmaceutical Corporation engages in the development and manufacture of active pharmaceutical and high purity ingredients.
Microtek provides innovative product development by incorporating microelectronics, bioscience and pharmaceutical strategies.
Clinitiative Health Research™ stands at the forefront of the clinical research industry as a distinguished global consulting and business development organization based in the United States. Specializing in fostering strategic connections between premier independent clinical research sites and site networks with pharmaceutical sponsors and clinical research organizations (CROs), Clinitiative Health Research™ is committed to enhancing the success rate of research studies worldwide. By leveraging their vast expertise and industry knowledge, the organization streamlines the clinical trial process, ensuring that all stakeholders can navigate the complex world of research and development with confidence and efficiency. As a trusted partner in the realm of clinical research, Clinitiative Health Research™ plays a pivotal role in bridging the gap between pioneering clinical sites and pharmaceutical organizations, ultimately driving progress and innovation in the field of healthcare. Visit www.clinitiative.com to learn more.
Rancho BioSciences is an international fee for service data curation company with analysis and developer services. Our customers include Pharma, Foundations, Government and Biotech. We have a team of experienced PhD and PhD/MD scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases and clinical data. Rancho BioSciences is flexible and cost effective providing on site or off site curators. Our goal and passion is to help find cures for diseases by serving our clients. Rancho BioSciences is on a mission to save lives through Data. Rancho BioSciences vision is to be the leading data services company in the world leveraging domain knowledge and expertise to solve complex problems.
ApotheCom is a Global Medical Communications Powerhouse with offices in London, Leeds, Yardley, New York, San Francisco, San Diego, Boston, Lebanon, Auckland, Tokyo and Johannesburg. Our mission is to be an effective and proactive broker of collaborative and sustained engagement for the healthcare community, to drive meaningful change and positive outcomes. ApotheCom is uniquely able to create and deploy teams across many geographies, pulling on specialized skills and specific market expertise. The team comprises 130 PhDs and PharmDs and more than 250 content developers who understand how to tell the scientific, clinical, and value stories to reach specific audiences. The global team structure supports dedicated practice areas in Scientific Communications and Publications, Medical Education and Access Pathways and Outcomes in addition to therapeutic areas of excellence across chronic diseases, oncology, vaccines and infectious diseases, cell and genes therapies and specialized medicine. The matrix structure has been created to fuel innovation and flexibility, with increased specialization and focus on multi-functional team working. At our core, we bring data agility, integrated evidence planning, scientific and value storytelling, convergence of technology and insight-driven problem-solving. Our single, global team structure with dedicated practice areas and defined therapeutic expertise has been specifically designed to remove every barrier to being able to provide the best expertise in the right place and at the right time for our clients. ApotheCom is part of Inizio Medical. Inizio is a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engagement services.
Antares Pharma is a revenue-generating product focused specialty pharmaceutical company
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Kiel Laboratories, Inc. is a pharmaceutical research and development company based out of 5659 Southfield Drive, Flowery Branch, Georgia, United States. With over 200 years of combined experience in formulation development, analytical services, manufacturing, clinical and regulatory affairs, consulting, and project management for pharmaceutical products. We are an employee-owned (ESOP) company. The Company develops intellectual property and technology for the submission of NDAs and commercialization of drug products. We develop and out license IP for drug products. We find and research pharmaceutical product ideas and assist partners in bringing them to market. We help our partners get their product ideas approved.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Sunovion Pharmaceuticals Inc. leads the way to a healthier tomorrow by creating medicines for respiratory diseases and central nervous system disorders.
Navigen is a drug discovery and development company creating new classes of therapies to save lives.
Monoceros Biosystems is a biotechnology company that offers personalized applications of bioinformatics in drug discovery.
Centrose is a biotechnology company engaged in the development and commercialization of therapeutics targeting disease related cells.
